Rheumatology NewsPeople with long COVID have specific blood biomarkers, study saysSeptember 27, 2023Long COVIDCOVID-19 Updates
Rheumatology NewsAre vitamin D levels key to canagliflozin’s fracture risk?September 25, 2023Osteoporosis
Rheumatology NewsPatients with rheumatism have premature immune system agingSeptember 22, 2023Rheumatoid Arthritis
Rheumatology NewsGinger consumption may mitigate neutrophil dysfunction and inflammationSeptember 22, 2023Lupus & Connective Tissue Diseases
Rheumatology NewsMortality in ankylosing spondylitis: CV disease, drug abuse are big contributorsSeptember 22, 2023SpondyloarthropathiesAnkylosing spondylitis
Tofacitinib can be considered as a treatment option for PsA with enthesitisSeptember 21, 2023Psoriatic Arthritis
Secukinumab offers sustained improvement in synovitis and enthesitis in active PsASeptember 21, 2023Psoriatic Arthritis
Real-world study confirms high retention rates and favorable safety of secukinumab in active PsASeptember 21, 2023Psoriatic Arthritis
Persistence and multidomain effectiveness of guselkumab in active PsASeptember 21, 2023Psoriatic Arthritis
Acitretin use poses no additional risk for PsA compared with DMARD in patients with psoriasisSeptember 21, 2023Psoriatic Arthritis
Failure of first-line IL-17A inhibitor should not deter treatment with second-line IL-17A September 21, 2023Psoriatic Arthritis
Biological DMARD equally effective in PsA patients with low or high joint countsSeptember 21, 2023Psoriatic Arthritis
